Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Bonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
BMC Cancer
|
December 19, 2021
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Min Shi, Zhongyin Yang, Sheng Lu, et al.
Infectious Diseases and Therapy
|
September 15, 2025
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV
Yanan Zheng, Mary Wire, Robert Were Omange, et al.
Clinical Pharmacology and Therapeutics
|
August 15, 2018
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle
Imke H Bartelink, Ella F Jones, Sheerin K Shahidi-Latham, et al.
Future Oncology (London, England)
|
May 22, 2023
Sintilimab combined neoadjuvant intraperitoneal and systemic chemotherapy in gastric cancer with peritoneal metastasis
Hong Yuan, Sheng Lu, Min Shi, et al.
The Lancet. HIV
|
February 2, 2024
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
Joseph J Eron, Susan J Little, Gordon Crofoot, et al.
Thorax
|
May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A Hanania, Michael Noonan, Jonathan Corren, et al.
Science Translational Medicine
|
July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
Gail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Infectious Diseases and Therapy
|
September 15, 2024
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod
Sharon A Riddler, Constance A Benson, Cynthia Brinson, et al.
Mabs
|
March 29, 2012
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
Yanan Zheng, Devin B Tesar, Lisa Benincosa, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors
Bonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
BMC Cancer
|
December 19, 2021
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
Min Shi, Zhongyin Yang, Sheng Lu, et al.
Infectious Diseases and Therapy
|
September 15, 2025
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV
Yanan Zheng, Mary Wire, Robert Were Omange, et al.
Clinical Pharmacology and Therapeutics
|
August 15, 2018
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle
Imke H Bartelink, Ella F Jones, Sheerin K Shahidi-Latham, et al.
Future Oncology (London, England)
|
May 22, 2023
Sintilimab combined neoadjuvant intraperitoneal and systemic chemotherapy in gastric cancer with peritoneal metastasis
Hong Yuan, Sheng Lu, Min Shi, et al.
The Lancet. HIV
|
February 2, 2024
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study
Joseph J Eron, Susan J Little, Gordon Crofoot, et al.
Thorax
|
May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A Hanania, Michael Noonan, Jonathan Corren, et al.
Science Translational Medicine
|
July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
Gail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
Infectious Diseases and Therapy
|
September 15, 2024
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod
Sharon A Riddler, Constance A Benson, Cynthia Brinson, et al.
Mabs
|
March 29, 2012
Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration
Yanan Zheng, Devin B Tesar, Lisa Benincosa, et al.
Page
of 13